GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 833 filers reported holding GLAXOSMITHKLINE PLC in Q2 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,518,000 | -1.5% | 57,849 | -1.2% | 0.04% | +8.6% |
| Q1 2022 | $2,557,000 | +7.8% | 58,571 | +8.9% | 0.04% | -2.8% |
| Q4 2021 | $2,372,000 | +32.5% | 53,784 | +14.9% | 0.04% | +20.0% |
| Q3 2021 | $1,790,000 | +15.7% | 46,811 | +20.5% | 0.03% | +7.1% |
| Q2 2021 | $1,547,000 | +10.8% | 38,859 | -0.6% | 0.03% | -6.7% |
| Q1 2021 | $1,396,000 | +1.9% | 39,102 | +5.2% | 0.03% | -9.1% |
| Q4 2020 | $1,370,000 | -47.0% | 37,171 | -45.7% | 0.03% | -19.5% |
| Q3 2020 | $2,586,000 | +103.5% | 68,497 | +119.8% | 0.04% | +10.8% |
| Q2 2020 | $1,271,000 | +11.9% | 31,162 | +4.3% | 0.04% | +8.8% |
| Q1 2020 | $1,136,000 | -15.7% | 29,888 | +4.1% | 0.03% | +9.7% |
| Q4 2019 | $1,347,000 | +286.0% | 28,719 | +250.0% | 0.03% | +121.4% |
| Q3 2019 | $349,000 | -8.2% | 8,206 | -13.6% | 0.01% | -17.6% |
| Q2 2019 | $380,000 | 0.0% | 9,496 | +4.4% | 0.02% | -15.0% |
| Q1 2019 | $380,000 | +8.6% | 9,095 | +0.6% | 0.02% | -66.1% |
| Q4 2018 | $350,000 | – | 9,043 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chubb Ltd | 400,000 | $15,404,000 | 6.76% |
| KAHN BROTHERS GROUP INC | 833,315 | $32,090,960,000 | 5.42% |
| Sio Capital Management, LLC | 180,811 | $6,963,000 | 4.06% |
| Sio Capital Management, LLC | 170,000 | $6,547,000 | 3.82% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,124,462 | $43,304,000 | 3.12% |
| Keystone Financial Planning, Inc. | 120,705 | $4,648,000 | 3.04% |
| PVG Asset Management | 186,553 | $7,184,156,000 | 3.02% |
| P.R. Herzig & Co. Inc. | 37,950 | $1,461,000 | 2.98% |
| EQUITY INVESTMENT CORP | 2,329,469 | $89,708,000 | 2.89% |
| Sterneck Capital Management, LLC | 114,816 | $4,422,000 | 2.84% |